Takeda Submits NDA for a Subcutaneous Formulation of Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis in Japan Read more
Big Pharma are investing huge amounts in data analytics, but what are the challenges and opportunities of using data? – Infographic: 2019 Latest Industry Trends Read more
Novartis stands behind Zolgensma (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy Read more
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial Read more